Foundation / Corporation
The Henry and Marilyn Taub Foundation
11/08/18 12:00 Noon, EDT
Grants to USA researchers for innovative, high-impact research on Myelodysplastic Syndromes, its treatment, and prevention. Priority is given to studies focusing on stem cells, molecular genetics, splicing factors, epigenetics, the microenvironment, and novel therapeutic targets relevant to MDS.
The Program specifically focuses on MDS research, exclusive of AML and MPN. The Program supports translational research that includes bidirectional efforts, building upon research in the laboratory and therapeutic outcomes in the clinic. Innovative studies with transformative potential to elucidate MDS etiology and to develop new treatments are particularly encouraged.
The award may be used to support the Award Recipient’s salary and fringe benefits; salaries and fringe benefits of postdoctoral fellows, technicians or graduate students; publication of scientific data; travel to scientific meetings; laboratory and data processing supplies; and other direct expenses such as equipment essential to the project. Salaries must be in proportion to the percent effort on the research project. However, percent effort may exceed the percent of total compensation requested from The Taub Foundation.
GrantWatch ID#: 180750
Up to four
Three-year awards of $600,000 ($200,000 per year, inclusive of 10% indirect costs)
Three-year grants will be awarded for the funding period of July 1, 2019 - June 30, 2022.
Awards will be made to independent investigators working in non-profit, non-governmental academic, medical, or research institutions within the United States. Collaborative efforts are encouraged.
All applicants must meet the following eligibility requirements:
- Hold a Ph.D., MD, M.D./Ph.D., or comparable degree, and a faculty appointment at a non-profit, academic, medical, or research institution in the United States.
- All applicants must be independent investigators with demonstrated institutional support and their own laboratory space to conduct the proposed research.
- Applicants may not have funding support for a similar project.
- Applicants may only submit one application as a PI.
- Applicants do not need to be nominated by their institutions.
- United States citizenship is not required; visa documentation is not required.
The Taub Program supports independent investigators at all stages of their careers. To promote the expansion of the MDS research field collaborative efforts and proposals from young investigators and those from non-MDS fields are encouraged to apply.
Funds may not be used for new construction, the renovation of existing facilities, fundraising projects or endowments. Funds may not be used for any political activity, accumulated deficits, or for any other purpose prohibited by the Internal Revenue Service Code. Funds awarded for the direct costs of the project may not be used for general operating costs.
Initial Proposal Online Application Deadline: Thursday, November 8, 2018 12:00 Noon, U.S. ET
The Taub Program is a two-step process.
Applicants must first submit an Initial Proposal. The Initial Proposal consists of an Online Application, a 2-page Research Proposal, Applicant Biosketch, and Co-Investigator Biosketch (if applicable).
Applicants selected from the Initial stage will be invited via email to submit Full Proposals, due in mid-March. The Full Proposal will include an Online Application, Application Face Sheet, Project Summary, ten-page Research Proposal, Applicant Biosketch, Co-Investigator Biosketch (if applicable), Budget and Justification Forms, Department or Division Head Letter, and Letter(s) of Collaboration (if applicable).
Before starting your grant application, please review the funding source's website listed below for updates/changes/addendums/conferences/LOIs.
Apply online: https://www.grantrequest.com/SID_738/default.asp?SA=SNA&FID=35073
Erin Johnstone, Program Officer, The Medical Foundation
Health Resources in Action
95 Berkeley St.
Boston, MA 02116
USA: Alabama; Alaska; Arizona; Arkansas; California; Colorado; Connecticut; Delaware; Florida; Georgia; Hawaii; Idaho; Illinois; Indiana; Iowa; Kansas; Kentucky; Louisiana; Maine; Maryland; Massachusetts; Michigan; Minnesota; Mississippi; Missouri; Montana; Nebraska; Nevada; New Hampshire; New Jersey; New Mexico; New York City; New York; North Carolina; North Dakota; Ohio; Oklahoma; Oregon; Pennsylvania; Rhode Island; South Carolina; South Dakota; Tennessee; Texas; Utah; Vermont; Virginia; Washington, DC; Washington; West Virginia; Wisconsin; Wyoming